FBInvestor
Stocks / Adaptimmune Therapeutics PLC
Institutional Ownership

Adaptimmune Therapeutics PLC

CUSIP 00653A107SPONDS ADSADAPYQ1 2026

Dividends

Dividends-per-share are sourced from SEC XBRL filings. Either this issuer doesn't declare a common dividend, or it isn't ingested yet (we cover the top issuers first).

Coming soon